Dr. Paul J. Nugent

Sleep Medicine
The Christ Hospital Urgent Care Center
4440 Red Bank Rd Ste 110, 
Cincinnati, OH 
The Christ Hospital Urgent Care Center
4440 Red Bank Rd Ste 110, 
Cincinnati, OH 

Overview

Paul Nugent is a Sleep Medicine provider practicing medicine in Cincinnati, Ohio.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 15 clinical trials.

Specialties

Sleep Medicine

Licenses

Family Medicine in OH

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

The Christ Hospital Urgent Care Center
4440 Red Bank Rd Ste 110, Cincinnati, OH 45227

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 21, 2026
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Biological
Study Drug: RSVPreF3
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: July 17, 2024
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: November 30, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Osteoarthritis
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: LY3016859
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Terminated
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
View 9 Less Clinical Trials

1 Total Publications

Why have so many African leaders died of COVID-19?
Why have so many African leaders died of COVID-19?
Journal: BMJ global health
Published: March 04, 2021
Similar Doctors
Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Cincinnati Childrens Hospital Medical Center Liberty Campus

7777 Yankee Rd, 
Liberty Township, OH 
 (15.5 miles away)
513-636-6771
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Narong Simakajornboon is a Sleep Medicine provider practicing medicine in Liberty Township, Ohio. Dr. Simakajornboon is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Central Sleep Apnea, Obstructive Sleep Apnea, Periodic Limb Movement Disorder, Restless Legs Syndrome, and Adenoidectomy. Dr. Simakajornboon is currently accepting new patients.

Expertise in
5
conditions
Dr. Stacey L. Ishman
Sleep Medicine
Expertise in
5
conditions
Dr. Stacey L. Ishman
Sleep Medicine
Referral may be required

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (6.2 miles away)
513-636-4355
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Stacey Ishman is a Sleep Medicine provider practicing medicine in Cincinnati, Ohio. Dr. Ishman is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Velopharyngeal Insufficiency, Insomnia, Adenoidectomy, and Glossectomy. Dr. Ishman is currently accepting new patients.

Expertise in
4
conditions
Dr. Sanjiv P. Patel
Sleep Medicine
Expertise in
4
conditions
Dr. Sanjiv P. Patel
Sleep Medicine
Referral may be required
Before you request

Mercy Health — Kenwood Sleep Medicine

4760 East Galbraith Road, Suite 203, 
Cincinnati, OH 
 (4.0 miles away)
513-774-2870
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sanjiv Patel is a Sleep Medicine provider practicing medicine in Cincinnati, Ohio. Dr. Patel is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Drowsiness, Excessive Daytime Sleepiness, Obstructive Sleep Apnea, and Central Sleep Apnea. Dr. Patel is board certified in American Board Of Sleep Medicine. Dr. Patel is currently accepting new patients.

Frequently Asked Questions about Dr. Paul J. Nugent

How do I make an appointment with Dr. Paul J. Nugent?

You can book an appointment with Dr. Paul J. Nugent by calling their office at 513-564-1366. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nugent's expertise for a condition
ConditionClose

We do not have enough information to identify the Areas of Expertise for this provider.

Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile